HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $269,993,505 | +2.8% | 2,333,767 | -8.6% | 0.06% | +3.7% |
Q2 2023 | $262,647,531 | +137.7% | 2,553,695 | +152.2% | 0.05% | +134.8% |
Q1 2023 | $110,510,144 | -50.7% | 1,012,554 | -48.6% | 0.02% | -59.6% |
Q4 2022 | $224,238,917 | +378.1% | 1,970,465 | +160.0% | 0.06% | +375.0% |
Q3 2022 | $46,904,000 | -11.2% | 757,879 | +14.4% | 0.01% | -7.7% |
Q2 2022 | $52,839,000 | -10.3% | 662,471 | +18.4% | 0.01% | +30.0% |
Q1 2022 | $58,884,000 | -42.5% | 559,674 | -41.1% | 0.01% | +233.3% |
Q4 2021 | $102,474,000 | +8.3% | 950,934 | +10.1% | 0.00% | -76.9% |
Q3 2021 | $94,602,000 | +14.1% | 863,636 | -2.4% | 0.01% | +8.3% |
Q2 2021 | $82,881,000 | -5.7% | 885,105 | -7.3% | 0.01% | -14.3% |
Q1 2021 | $87,880,000 | -39.9% | 954,801 | -52.3% | 0.01% | +27.3% |
Q4 2020 | $146,338,000 | +242.3% | 2,000,512 | +263.5% | 0.01% | +37.5% |
Q3 2020 | $42,751,000 | +87.5% | 550,345 | +34.2% | 0.01% | +60.0% |
Q2 2020 | $22,795,000 | +82.1% | 410,127 | -2.9% | 0.01% | +66.7% |
Q1 2020 | $12,515,000 | -53.9% | 422,503 | -43.7% | 0.00% | -62.5% |
Q4 2019 | $27,175,000 | +143.1% | 750,692 | +82.8% | 0.01% | +100.0% |
Q3 2019 | $11,180,000 | -7.7% | 410,587 | -18.4% | 0.00% | +300.0% |
Q2 2019 | $12,107,000 | – | 503,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |